Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Tiribelli

Showing results (41-50 of 292) with videos related to

Pageof 30
Sort By:
Frontiers in Bioscience (Landmark Edition)|May 31, 2022
Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular CarcinomaChiara Andolfi, Claudio Tiribelli, Devis Pascut
Expert Review of Gastroenterology & Hepatology|October 29, 2013
The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapyCaecilia H C Sukowati, Claudio Tiribelli
Bioscience Reports|February 24, 2015
Silencing efficacy prediction: a retrospective study on target mRNA featuresDevis Pascut, Giorgio Bedogni, Claudio Tiribelli
Annals of Hepatology|June 3, 2025
Data mining reveals novel gene drivers of lenvatinib resistance in hepatocellular carcinomaCyrollah Disoma, Claudio Tiribelli, Caecilia Sukowati
Trends in Molecular Medicine|June 14, 2005
Bilirubin and the risk of common non-hepatic diseasesIgino Rigato, J Donald Ostrow, Claudio Tiribelli
Pediatric Research|December 10, 2003
Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitroJay Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
Annals of Hepatology|March 26, 2004
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infectionGianna Dal Molin, Claudio Tiribelli, Cesare Campello
Pediatric Research|November 11, 2020
Transcutaneous bilirubin measurements: useful, but also reproducible?Carlo Dani, Christian V Hulzebos, Claudio Tiribelli
Bioscience Trends|November 12, 2010
Unconjugated bilirubin modulates nitric oxide production via iNOS regulationGraciela L Mazzone, Igino Rigato, Claudio Tiribelli
Hepatic Oncology|July 11, 2020
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillanceDevis Pascut, Muhammad Yogi Pratama, Claudio Tiribelli
Pageof 30

Showing results (41-50 of 292) with videos related to

Sort By:
Pageof 30
Frontiers in Bioscience (Landmark Edition)|May 31, 2022
Recent Hints on the Dual Role of Discs Large MAGUK Scaffold Protein 5 in Cancers and in Hepatocellular CarcinomaChiara Andolfi, Claudio Tiribelli, Devis Pascut
Expert Review of Gastroenterology & Hepatology|October 29, 2013
The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapyCaecilia H C Sukowati, Claudio Tiribelli
Bioscience Reports|February 24, 2015
Silencing efficacy prediction: a retrospective study on target mRNA featuresDevis Pascut, Giorgio Bedogni, Claudio Tiribelli
Annals of Hepatology|June 3, 2025
Data mining reveals novel gene drivers of lenvatinib resistance in hepatocellular carcinomaCyrollah Disoma, Claudio Tiribelli, Caecilia Sukowati
Trends in Molecular Medicine|June 14, 2005
Bilirubin and the risk of common non-hepatic diseasesIgino Rigato, J Donald Ostrow, Claudio Tiribelli
Pediatric Research|December 10, 2003
Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitroJay Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
Annals of Hepatology|March 26, 2004
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infectionGianna Dal Molin, Claudio Tiribelli, Cesare Campello
Pediatric Research|November 11, 2020
Transcutaneous bilirubin measurements: useful, but also reproducible?Carlo Dani, Christian V Hulzebos, Claudio Tiribelli
Bioscience Trends|November 12, 2010
Unconjugated bilirubin modulates nitric oxide production via iNOS regulationGraciela L Mazzone, Igino Rigato, Claudio Tiribelli
Hepatic Oncology|July 11, 2020
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillanceDevis Pascut, Muhammad Yogi Pratama, Claudio Tiribelli
Pageof 30